Source: Alzheimer's & Dementia. Unidades: FM, ICB
Subjects: FISIOLOGIA, FARMACOLOGIA, DOENÇA DE ALZHEIMER, LÍTIO, TRANSTORNO BIPOLAR, CAMUNDONGOS, IMUNOHISTOQUÍMICA
ABNT
SINGULANI, Monique Patricio et al. Lithium as a pharmacological approach to treat behavioral complications in Alzheimer’s disease: a preclinical study. Alzheimer's & Dementia, v. 20, n. S1, p. 2 , 2024Tradução . . Disponível em: https://doi.org/10.1002/alz.090340. Acesso em: 04 jan. 2026.APA
Singulani, M. P., Talib, L. L., Forlenza, O. V., Britto, L. R. G. de, & Camarini, R. (2024). Lithium as a pharmacological approach to treat behavioral complications in Alzheimer’s disease: a preclinical study. Alzheimer's & Dementia, 20( S1), 2 . doi:10.1002/alz.090340NLM
Singulani MP, Talib LL, Forlenza OV, Britto LRG de, Camarini R. Lithium as a pharmacological approach to treat behavioral complications in Alzheimer’s disease: a preclinical study [Internet]. Alzheimer's & Dementia. 2024 ; 20( S1): 2 .[citado 2026 jan. 04 ] Available from: https://doi.org/10.1002/alz.090340Vancouver
Singulani MP, Talib LL, Forlenza OV, Britto LRG de, Camarini R. Lithium as a pharmacological approach to treat behavioral complications in Alzheimer’s disease: a preclinical study [Internet]. Alzheimer's & Dementia. 2024 ; 20( S1): 2 .[citado 2026 jan. 04 ] Available from: https://doi.org/10.1002/alz.090340
